VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
COO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
COOThe Cooper Companies, Inc.
$62.36$12.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
COO logo

The Cooper Companies, Inc.

COO
NASDAQ · Eye & Dental Care
$62.36
At close - Nov 6, 4:00 PM EST - USD
Market Cap$12.16B
P/E21.1x
52W High$89.83
Volume2.06M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Acquisition Integration and Growth Deceleration Pressuring Margins

The Cooper Companies faces a critical transition as post-pandemic demand normalization in its vision care segment leads to decelerating revenue growth, falling to just 0.6% in the latest quarter.

GrowthDecelerating
ProfitabilityModerate
ValuationAttractive
TechnicalsWeak
Explore valuation models
MARKET ACTION

COO price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

11/12 Beats

EPS beat 11 of last 12 quarters

02

Valuation risk

-31% Peers

P/E is 31% below peer median

03

Market leadership

RS 43 · Lag

Laggard (Underperforming 57% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystConfirmed earnings · Dec 3
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth has decelerated significantly to 0.6% in 2026Q3 from a high of 9.8% in 2024Q4, while gross margins have exhibited high volatility, swinging from 56.4% in 2025Q4 to 68.0% in 2026Q2.

Analyst Consensus+4.4% target
Buy(28 analysts)
14 Buy13 Hold1 Sell

The Bull Case

Upside Catalysts

Strong revenue guidance

The company has provided optimistic earnings guidance for fiscal year 2026, expecting total revenue of $4.285 billion - $4.321 billion with organic growth of 3.5% to 4.5%.

Robust financial performance

The Cooper Companies reported strong fourth-quarter and full-year 2025 results, with sales rising to $1,065.2 million and $4,092.4 million respectively, alongside positive net income and diluted EPS.

Diverse healthcare network

The company operates 130 primary and specialty care offices with 1,900 physicians and advanced practice providers, offering expert care in 95 specialties, indicating a strong and diversified healthcare presence.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
COO-23.12%
S&P 500 (^GSPC)+7.63%
1-Year Return
COO-9.62%
S&P 500 (^GSPC)+9.69%
3-Year Return
COO-25.43%
S&P 500 (^GSPC)+66.42%
5-Year Return
COO-42.18%
S&P 500 (^GSPC)+54.47%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
21.1x
Forward P/EExpansion
13.8x
EV/EBITDA20th %ile
16.0x
FCF YieldCash Flow
5.6%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
21.1x
37.4x
20th· Low
EV/EBITDA
16.0x
20.0x
20th· Low
Price/FCF
17.9x
39.6x
0th· Low
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$47.71-23.5%
Base (Fair)$86.80+39.2%
Bull$159.37+155.6%
$47.71 Bear$86.80 Base$159.37 Bull
Current Market Price: $62.36
Trades at a 28.2% discount to Base DCF ($86.80)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$4.09B+5.1% YoY
Net income FY25
$375M-4.4% YoY
Free cash flow FY25
$434M+50.5% YoY
Operating margin FY25
16.7%-1.4 pts YoY
ROIC (FY25)4.8%
Avg ROIC 5Y4.7%
ROE (TTM)6.9%
Piotroski Score5 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate11/12 (92%)
Revenue Beat Rate7/12 (58%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Sep 9, 2026
$1.15+2.7%
vs $1.12
$1.1B-2.9%
vs $1.1B
Q3 2026
Jun 4, 2026
$1.21+10.0%
vs $1.10
$1.1B+2.6%
vs $1.1B
Q2 2026
Mar 5, 2026
$1.10+6.8%
vs $1.03
$1.0B+0.0%
vs $1.0B
Q4 2025
Dec 4, 2025
$1.15+3.6%
vs $1.11
$1.1B+0.4%
vs $1.1B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
GlobeNewsWire·Oct 27, 2026
CooperCompanies Announces Leadership Transition and Board Refreshment

Independent Director and Seasoned Healthcare Executive Walt Rosebrough  Elected Executive Chair; Search for CEO Underway

Zacks Investment Research·Oct 9, 2026
Why Is The Cooper Companies (COO) Up 0.2% Since Last Earnings Report?

The Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock?

The Motley Fool·Sep 26, 2026
AST SpaceMobile COO Dumps 12,000 Shares for $707,000 Amid a 47% One-Year Return

The disposition involved 12,000 shares at a weighted average price of $58.89 per share, totaling ~$707,000. The transaction size was equal to 3% of the equity stake held before the filing.

Reuters·Sep 18, 2026
Jana urges Cooper to replace CEO, explore asset sales after performance setbacks

Activist investor Jana Partners on Friday urged Cooper Companies to launch an external search for a new CEO and consider ​asset sales, arguing recent missteps have hurt investor ‌confidence and weighed on the medical device maker's market value.

Filtered for The Cooper Companies, Inc.More Headlines
04

Compare before deciding

Benchmark COO against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for The Cooper Companies, Inc. (COO)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
COO logoCOOThe Cooper Companies, Inc.Current
$62.36$12.16B21.155.06%13.46%6.88%—
BLCO logoBLCOBausch + Lomb Corporation
$19.99$7.14B-65.096.47%-2.05%-1.71%—
EW logoEWEdwards Lifesciences Corporation
$102.14$58.81B57.7711.55%15.3%9.65%—
HSIC logoHSICHenry Schein, Inc.
$86.05$9.8B23.004.03%3.07%8.83%—
JNJ logoJNJJohnson & Johnson
$276.22$664.92B42.026.05%16.2%19.55%1.85%
ABT logoABTAbbott Laboratories
$109.93$191.48B40.645.67%9.75%9%2.14%

Compare COO vs Peers

The Cooper Companies, Inc. (COO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BLCO

Most directly comparable listed peer for COO.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare COO against a more recognizable public peer.

Peer Set

Compare Top 5

vs BLCO, EW, HSIC, JNJ

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

COO SEC Filings & Documents

The Cooper Companies, Inc. (COO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Sep 9, 2026·SEC

Material company update

Jun 4, 2026·SEC

Material company update

May 4, 2026·SEC

10-K Annual Reports

4
FY 2025

Dec 5, 2025·SEC

FY 2024

Dec 6, 2024·SEC

FY 2023

Dec 8, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

Sep 9, 2026·SEC

FY 2026

Jun 5, 2026·SEC

FY 2026

Mar 6, 2026·SEC

Get notified when COO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

COO Frequently Asked Questions

The Cooper Companies, Inc. (COO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is The Cooper Companies, Inc.'s revenue?

The Cooper Companies, Inc. (COO) reported $4.24B in revenue over the trailing twelve months. Revenue was $4.09B in fiscal year 2025. That is 3651% more than the $109.1M of fiscal year 1996.

How fast is The Cooper Companies, Inc. growing?

The Cooper Companies, Inc. (COO) grew revenue by 4.7% over the trailing twelve months, compared with the twelve months before.

Is COO profitable?

Yes. The Cooper Companies, Inc. (COO) earned $570.3M in net income over the trailing twelve months (a 13.5% net margin).

Dividend & Returns
What is COO's return on equity?

The Cooper Companies, Inc. (COO) had a return on equity (ROE) of 6.9% over the trailing twelve months. That is below the market's typical 10-15%.

What is The Cooper Companies, Inc.'s free cash flow?

The Cooper Companies, Inc. (COO) generated $678.0M in free cash flow over the trailing twelve months.

What if you invested $1,000 in COO back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →